• “How I treat” a patient with DNMT3A-mutated AML in remission post intensive chemotherapy

  • Oct 3 2024
  • Duración: 6 m
  • Podcast

“How I treat” a patient with DNMT3A-mutated AML in remission post intensive chemotherapy

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • The AML Hub was pleased to speak with Cristina Papayannidis, Universitaria di Bologna, Bologna, IT. We asked, How do you treat a patient with DNMT3A-mutated acute myeloid leukemia (AML) in remission post intensive chemotherapy?

    This educational resource is independently supported by Bristol Myers Squibb. All content is developed by SES in collaboration with an expert steering committee; funders are allowed no influence on the content of this resource.

    Hosted on Acast. See acast.com/privacy for more information.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre “How I treat” a patient with DNMT3A-mutated AML in remission post intensive chemotherapy

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles